A pilot study of forbretabulin with bevacizumab in recurrent high-grade gliomas

被引:1
|
作者
Altaha, R. [1 ]
Almubarak, M. [1 ]
Newton, M. D. [1 ]
Torres-Trejo, A. [1 ]
Marano, G. [1 ]
Hobbs, G. [1 ]
Gibson, L. [1 ]
Petros, W. P. [1 ]
Remick, S. C. [1 ]
机构
[1] W Virginia Univ, Sch Med, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.tps147
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS147
引用
收藏
页数:1
相关论文
共 50 条
  • [1] BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMAS
    Sahebjam, Solmaz
    Garoufalis, Evgenia
    Guiot, Marie Christine
    Muanza, Thierry
    Del Maestro, Ronaldo
    Kavan, Petr
    [J]. NEURO-ONCOLOGY, 2010, 12 : 43 - 43
  • [2] Bevacizumab in recurrent high-grade pediatric gliomas
    Narayana, Ashwatha
    Kunnakkat, Saroj
    Chacko-Mathew, Jeena
    Gardner, Sharon
    Karajannis, Matthias
    Raza, Shahzad
    Wisoff, Jeffrey
    Weiner, Howard
    Harter, David
    Allen, Jeffrey
    [J]. NEURO-ONCOLOGY, 2010, 12 (09) : 985 - 990
  • [3] Bevacizumab in Recurrent High-Grade Gliomas: A Canadian Retrospective Study
    Fat, Mary Jane Lim
    Maurice, Catherine
    Maganti, Manjula
    Mason, Warren P.
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2018, 45 (01) : 56 - 61
  • [4] Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients
    Schernberg, A.
    Dhermain, F.
    Ammari, S.
    Dumont, S. N.
    Domont, J.
    Patrikidou, A.
    Pallud, J.
    Dezamis, E.
    Deutsch, E.
    Louvel, G.
    [J]. CANCER RADIOTHERAPIE, 2018, 22 (01): : 9 - 16
  • [5] Effectiveness of Stereotactic Radiotherapy and Bevacizumab for Recurrent High-Grade Gliomas: A Potential Therapy for Isocitrate Dehydrogenase Wild-Type Recurrent High-Grade Gliomas
    Yasuda, Takayuki
    Muragaki, Yoshihiro
    Nitta, Masayuki
    Miyamoto, Kazunari
    Oura, Yuko
    Henmi, Takuo
    Noguchi, Sanshiro
    Oda, Hideaki
    Saito, Taiichi
    Maruyama, Takashi
    Atsuchi, Shoko
    Miura, Naohisa
    Kawamata, Takakazu
    [J]. WORLD NEUROSURGERY, 2018, 114 : E1138 - E1146
  • [6] Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas
    Asim K. Bag
    Hyunki Kim
    Yi Gao
    Mark Bolding
    Paula P. Warren
    Hassan M. Fathallah-Shaykh
    Demet Gurler
    James M. Markert
    John Fiveash
    Timothy M. Beasley
    Ayaz Khawaja
    Gregory K. Friedman
    Philip R. Chapman
    Louis B. Nabors
    Xiaosi Han
    [J]. Journal of Neuro-Oncology, 2015, 122 : 585 - 593
  • [7] Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas
    Bag, Asim K.
    Kim, Hyunki
    Gao, Yi
    Bolding, Mark
    Warren, Paula P.
    Fathallah-Shaykh, Hassan M.
    Gurler, Demet
    Markert, James M.
    Fiveash, John
    Beasley, Timothy M.
    Khawaja, Ayaz
    Friedman, Gregory K.
    Chapman, Philip R.
    Nabors, Louis B.
    Han, Xiaosi
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 122 (03) : 585 - 593
  • [8] Salvage therapy with bevacizumab and chemotherapy (irinotecan or fotemustine) in recurrent high-grade gliomas
    Trevisan, E.
    Laguzzi, E.
    Picco, E.
    Ruda, R.
    Crasto, S. Greco
    Gaidolfi, E.
    Fabrini, M. G.
    Scotti, V.
    Caroli, M.
    Bazzoli, E.
    Guarneri, D.
    Soffietti, R.
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 : S53 - S53
  • [9] TREATMENT OF CHILDREN WITH RECURRENT OR PROGRESSIVE HIGH-GRADE GLIOMAS WITH IRINOTECAN, TEMOZOLOMIDE, AND BEVACIZUMAB
    Parekh, Chintan
    Jubran, Rima
    Finlay, Jonathan
    Dhall, Girish
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 834 - 834
  • [10] Reirradiation and concurrent bevacizumab high-grade recurrent gliomas: experience and perspectives.
    Schernberg, A.
    Dhermain, F.
    Dumont, S.
    Patrikidou, A.
    Domont, J.
    Pallud, J.
    Deutsch, E.
    Louvel, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S610 - S610